Cross-species serum antibody detection by direct immunoglobulin catalysis

直接免疫球蛋白催化跨物种血清抗体检测

基本信息

  • 批准号:
    1706518
  • 负责人:
  • 金额:
    $ 39.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-01 至 2020-07-31
  • 项目状态:
    已结题

项目摘要

Current medical practice to diagnose Lyme disease by observation of symptoms combined with blood testing produces a lot of errors. The long-term goal is to develop a new approach that overcomes this limitation in Lyme disease testing and to create a general (cross­species) test for Lyme disease that can be used in humans, pets, livestock, and wild animals. The proposed research takes advantage of a largely-unknown property of the antibodies that form in response to Lyme infection that can be conveniently measured by their chemical reactivity. Lyme disease is the most common vector­borne disease in the United States, infecting 300,000 Americans per year. Current medical practice is to diagnose Lyme disease by observation of symptoms combined with serological detection of the host animal's antibodies against Borrelia antigens using ELISA and Western blot. Both of them have their limitations, namely, the secondary reagents exhibit nonspecific binding. The secondary antibodies make the test specific to the species providing the serum. Inexpensive, isotype- and species-independent antibody sensors are important because they can facilitate widespread monitoring of infectious disease, the cross-species study of the dynamics of seroconversion and early detection following exposure. The long-term goal is to implement and standardize a new biosensor based on direct measurement of antibody catalysis via the antibody-catalyzed water oxidation pathway (ACWOP). The objective is to elucidate the physiochemistry of antigen immobilization and catalytic sensing which produces hydrogen peroxide for a colorimetric or electrochemical readout. Three research aims will be pursued; namely, experimentally show antigen localization and specific antibody binding on paper substrates; show ELISA-level sensitivity from direct catalytic readout of bound antibodies; and, show detection of Borrelia antigens in clinically relevant samples. The key features are novel ACWOP-transduction mechanism that eliminates secondary antibodies from immune-specific sensors and practical implementation of immobilization chemistry that is resistant to nonspecific binding. It is anticipated that the proposed biosensor will have a significant practical impact because species­independent detection of Lyme borreliosis enables monitoring of the Borrelia reservoir as well as livestock, companion animals, and humans.
目前通过观察症状结合血液检测来诊断莱姆病的医疗实践产生了很多错误。 长期目标是开发一种新的方法,克服莱姆病测试中的这一限制,并创建一种可用于人类,宠物,牲畜和野生动物的莱姆病通用(跨物种)测试。这项拟议中的研究利用了抗体的一个很大程度上未知的特性,该特性是在对莱姆病感染做出反应时形成的,可以通过它们的化学反应性方便地测量。莱姆病是美国最常见的病媒传播疾病,每年感染30万美国人。 目前的医学实践是通过观察症状结合使用ELISA和Western印迹检测宿主动物针对疏螺旋体抗原的抗体来诊断莱姆病。它们都有其局限性,即第二试剂表现出非特异性结合。 第二抗体使测试对提供血清的物种具有特异性。廉价的、不依赖同种型和物种的抗体传感器很重要,因为它们可以促进传染病的广泛监测、血清转化动态的跨物种研究和接触后的早期检测。 长期目标是实现和标准化一种新的生物传感器,该生物传感器基于通过抗体催化水氧化途径(ACWOP)直接测量抗体催化。目的是阐明抗原固定和催化传感的生理化学,产生过氧化氢的比色或电化学读数。将追求三个研究目标;即,实验显示抗原定位和特异性抗体结合在纸基板上;显示ELISA水平的灵敏度从结合抗体的直接催化读出;和,显示在临床相关样品中的疏螺旋体抗原的检测。关键特征是新的ACWOP-转导机制,其从免疫特异性传感器中消除了二抗,并且实际实施了对非特异性结合具有抗性的固定化化学。预计所提出的生物传感器将具有显著的实际影响,因为莱姆疏螺旋体病的物种独立检测使得能够监测疏螺旋体储库以及牲畜、伴侣动物和人类。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian Kirby其他文献

Prevalence of psoriasis in patients with alcoholic liver disease
酒精性肝病患者银屑病的患病率
  • DOI:
    10.1111/j.1365-2230.2008.03140.x
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Anne‐Marie Tobin;E. M. Higgins;S. Norris;Brian Kirby
  • 通讯作者:
    Brian Kirby
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis
阿达木单抗治疗严重顽固性慢性斑块状银屑病
  • DOI:
    10.1111/j.1365-2230.2008.03161.x
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Caitriona Ryan;Brian Kirby;P. Collins;Sarah Rogers
  • 通讯作者:
    Sarah Rogers
Reversibility of alexithymia with effective treatment of moderate‐to‐severe psoriasis: longitudinal data from EPIDEPSO
有效治疗中重度银屑病可逆述情障碍:来自 EPIDEPSO 的纵向数据
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    10.3
  • 作者:
    F. Sampogna;Lluís Puig;P. Spuls;G. Girolomoni;MA Radtke;Brian Kirby;Miriam Brunori;P. Bergmans;P. Smirnov;J. Rundle;A. Castiglia;F. Lavie;Carle Paul
  • 通讯作者:
    Carle Paul
THE ROLE OF ANTI-MULLERIAN HORMONE IN THE EVALUATION OF THE EFFECTIVENESS OF METFORMIN HYDROCHLORIDE THERAPY IN POLYCYSTIC OVARIAN SYNDROME
抗苗勒氏管激素在评价盐酸二甲双胍治疗多囊卵巢综合征疗效中的作用
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mark D.P. Davis;M. Daoud;Brian Kirby;Lawrence E. Gibson;Roy S. Rogers
  • 通讯作者:
    Roy S. Rogers
43878 Bimekizumab versus secukinumab for the treatment of nail psoriasis in patients with moderate to severe plaque psoriasis: Results from the BE RADIANT phase 3b trial
  • DOI:
    10.1016/j.jaad.2023.07.094
  • 发表时间:
    2023-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Kilian Eyerich;Alice B. Gottlieb;Stefano Piaserico;Stefan Beissert;Melinda Gooderham;Brian Kirby;Nicola Tilt;Cynthia Madden;Susanne Wiegratz;Dirk de Cuyper;Boni Elewski
  • 通讯作者:
    Boni Elewski

Brian Kirby的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian Kirby', 18)}}的其他基金

Real-time, Acoustic Tuning of the Rheology of Shear-Thickening Suspensions
剪切增稠悬浮液流变学的实时声学调节
  • 批准号:
    1804963
  • 财政年份:
    2018
  • 资助金额:
    $ 39.93万
  • 项目类别:
    Standard Grant
Impedance Cytometry for Rapid Biosensing of Lipid Content in Algal Cultures
用于快速生物传感藻类培养物中脂质含量的阻抗细胞术
  • 批准号:
    1605574
  • 财政年份:
    2016
  • 资助金额:
    $ 39.93万
  • 项目类别:
    Standard Grant
UNS: Stem Cell Differentiation and Teratoma-forming Potential in hiPSC-derived Neural Cultures
UNS:hiPSC 来源的神经培养物中的干细胞分化和畸胎瘤形成潜力
  • 批准号:
    1511914
  • 财政年份:
    2015
  • 资助金额:
    $ 39.93万
  • 项目类别:
    Standard Grant
Conference: 2011 Microfluidics, Physics & Chemistry of Gordon Research Conference and Gordon Research Seminar, Waterville Valley, NH, July 1, 2011
会议:2011 微流体学、物理学
  • 批准号:
    1116569
  • 财政年份:
    2011
  • 资助金额:
    $ 39.93万
  • 项目类别:
    Standard Grant
Cellular and molecular bioseparations using coherently patterned micro/nano devices
使用相干图案微/纳米设备进行细胞和分子生物分离
  • 批准号:
    0828997
  • 财政年份:
    2008
  • 资助金额:
    $ 39.93万
  • 项目类别:
    Standard Grant

相似国自然基金

一种新型亚铁过氧化物酶对水稻叶脉组织的光保护作用及其机制研究
  • 批准号:
    Z25C130012
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
花胶鱼类物种Species-specific PCR和Multiplex PCR鉴定体系研究
  • 批准号:
    31902373
  • 批准年份:
    2019
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
山果蝇物种亚群(Drosophila montium species-subgroup)求偶行为及求偶歌进化及其相关基因研究
  • 批准号:
    31372187
  • 批准年份:
    2013
  • 资助金额:
    78.0 万元
  • 项目类别:
    面上项目
Beclin1复合体在神经酰胺三己糖苷诱导Fabry病自噬障碍中的调控作用及机制研究
  • 批准号:
    81100840
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
  • 批准号:
    10667861
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
人类SLE致病变异N​​CF1.pR90H在促进肾脏损伤中的作用
  • 批准号:
    10740630
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
Multifaceted role of MG53 in alleviating neuromuscular function decline in ALS
MG53 在缓解 ALS 神经肌肉功能衰退中的多方面作用
  • 批准号:
    10681888
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
Modulation of Protein S-nitrosylation Signaling as a Potential Therapeutic Breakthrough in Rheumatoid Arthritis
调节蛋白质 S-亚硝基化信号传导是类风湿关节炎的潜在治疗突破
  • 批准号:
    10817318
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
Mechanism of neutrophilic NCF1 in alcohol-associated liver disease pathogenesis
中性粒细胞NCF1在酒精相关性肝病发病机制中的作用机制
  • 批准号:
    10723321
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female Heart
压力会阻碍雌激素对女性心脏的抗氧化保护,从而加剧心肌缺血性损伤
  • 批准号:
    10715407
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
Brain Metabolites, Brain Antioxidant, and Cerebral Blood Flow Deficits in Single Ventricle Heart Disease
单心室心脏病中的脑代谢物、脑抗氧化剂和脑血流缺陷
  • 批准号:
    10644553
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
用于抑制骨转移肿瘤中 Gli2 的下一代靶向纳米颗粒
  • 批准号:
    10623705
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
Outer hair cells and noise-induced hearing loss
外毛细胞和噪音引起的听力损失
  • 批准号:
    10862034
  • 财政年份:
    2023
  • 资助金额:
    $ 39.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了